enGene Holdings Statistics

Total Valuation

enGene Holdings has a market cap or net worth of $320.64 million. The enterprise value is $107.33 million.

Market Cap	320.64M
Enterprise Value	107.33M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

enGene Holdings has 50.98 million shares outstanding. The number of shares has increased by 5,355.08% in one year.

Current Share Class	n/a
Shares Outstanding	50.98M
Shares Change (YoY)	+5,355.08%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	17.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.18
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.87, with a Debt / Equity ratio of 0.09.

Current Ratio	16.87
Quick Ratio	16.28
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.26

Financial Efficiency

Return on equity (ROE) is -31.96% and return on invested capital (ROIC) is -20.50%.

Return on Equity (ROE)	-31.96%
Return on Assets (ROA)	-19.56%
Return on Invested Capital (ROIC)	-20.50%
Return on Capital Employed (ROCE)	-21.01%
Revenue Per Employee	n/a
Profits Per Employee	-$967,404
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-19,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.81% in the last 52 weeks. The beta is -0.65, so enGene Holdings's price volatility has been lower than the market average.

Beta (5Y)	-0.65
52-Week Price Change	-78.81%
50-Day Moving Average	0.96
200-Day Moving Average	1.53
Relative Strength Index (RSI)	40.06
Average Volume (20 Days)	9,452

Short Selling Information

The latest short interest is 39, so 0.00% of the outstanding shares have been sold short.

Short Interest	39
Short Previous Month	2,992
Short % of Shares Out	0.00%
Short % of Float	0.00%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-62.30M
Pretax Income	n/a
Net Income	-55.14M
EBITDA	-62.21M
EBIT	-62.30M
Earnings Per Share (EPS)	-$1.46

Full Income Statement

Balance Sheet

The company has $238.33 million in cash and $25.02 million in debt, giving a net cash position of $213.31 million or $4.18 per share.

Cash & Cash Equivalents	238.33M
Total Debt	25.02M
Net Cash	213.31M
Net Cash Per Share	$4.18
Equity (Book Value)	272.61M
Book Value Per Share	5.35
Working Capital	232.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.28 million and capital expenditures -$925,000, giving a free cash flow of -$49.21 million.

Operating Cash Flow	-48.28M
Capital Expenditures	-925,000
Free Cash Flow	-49.21M
FCF Per Share	-$0.97

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

enGene Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5,355.08%
Shareholder Yield	-5,355.08%
Earnings Yield	-17.20%
FCF Yield	-15.35%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2